S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies

Orchard Therapeutics (ORTX) Insider Trading & Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Orchard Therapeutics (NASDAQ:ORTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.91%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$18,600.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get ORTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchard Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ORTX Insider Buying and Selling by Quarter

Orchard Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2022Bobby GasparCEOBuy1,500$7.40$11,100.00  
4/1/2022Frank E ThomasInsiderBuy1,000$7.50$7,500.00  
(Data available from 1/1/2013 forward)

ORTX Insider Trading Activity - Frequently Asked Questions

Who is on Orchard Therapeutics's Insider Roster?

The list of insiders at Orchard Therapeutics includes Bobby Gaspar, and Frank E Thomas. Learn more on insiders at ORTX.

What percentage of Orchard Therapeutics stock is owned by insiders?

2.91% of Orchard Therapeutics stock is owned by insiders. Learn more on ORTX's insider holdings.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ORTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners